abstract |
Disclosed herein is a method of treating pulmonary disease comprising administering to a patient an effective dose of an atomized liposomal amikacin formulation over at least one treatment cycle, wherein: The treatment cycle includes a 15-75 day dosing period and a concomitant 15-75 day non-dosing period, and the effective dose includes amikacin in the range of 100-2,500 mg daily during the dosing period. Including. |